Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | -1.29% | -0.65% | -5.28% |
30/04 | B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
29/04 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.28% | 219M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ligand Acquires 13% Stake in Ovid Therapeutics' Soticlestat Royalties for $30 Million